ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08585
0,03%
Bitcoin
69.891,55
-0,34%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Celcuity Inc (CELC)

  7. Celcuity Inc (CELC) News

CELC

Celcuity (CELC)

Celcuity Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CELC
DatumZeitQuelleÜberschriftSymbolFirma
20/05/202423h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CELCCelcuity Inc
15/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELCCelcuity Inc
15/05/202422h01GlobeNewswire Inc.Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate UpdateNASDAQ:CELCCelcuity Inc
13/05/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELCCelcuity Inc
08/05/202413h05GlobeNewswire Inc.Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference CallNASDAQ:CELCCelcuity Inc
04/04/202413h05GlobeNewswire Inc.Celcuity To Present at Upcoming Needham and Stifel Investor ConferencesNASDAQ:CELCCelcuity Inc
27/03/202421h01GlobeNewswire Inc.Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:CELCCelcuity Inc
20/03/202412h05GlobeNewswire Inc.Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference CallNASDAQ:CELCCelcuity Inc
06/03/202413h05GlobeNewswire Inc.Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024NASDAQ:CELCCelcuity Inc
28/02/202413h05GlobeNewswire Inc.Celcuity to Participate in Cowen’s 44th Annual Health Care ConferenceNASDAQ:CELCCelcuity Inc
23/02/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELCCelcuity Inc
22/02/202422h05GlobeNewswire Inc.Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate CancerNASDAQ:CELCCelcuity Inc
20/02/202413h05GlobeNewswire Inc.Celcuity Appoints Eldon Mayer as Chief Commercial OfficerNASDAQ:CELCCelcuity Inc
15/02/202423h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELCCelcuity Inc
15/02/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELCCelcuity Inc
15/02/202402h28Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CELCCelcuity Inc
14/02/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CELCCelcuity Inc
09/02/202416h32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CELCCelcuity Inc
07/02/202423h15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CELCCelcuity Inc
22/12/202322h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELCCelcuity Inc
20/12/202316h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CELCCelcuity Inc
06/12/202314h30GlobeNewswire Inc.Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer SymposiumNASDAQ:CELCCelcuity Inc
05/12/202323h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELCCelcuity Inc
01/12/202317h02GlobeNewswire Inc.Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer SymposiumNASDAQ:CELCCelcuity Inc
30/11/202322h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELCCelcuity Inc
29/11/202322h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CELCCelcuity Inc
29/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CELCCelcuity Inc
27/11/202320h59Edgar (US Regulatory)Form D/A - Notice of Exempt Offering of Securities: [Amend]NASDAQ:CELCCelcuity Inc
27/11/202320h53Edgar (US Regulatory)Form D/A - Notice of Exempt Offering of Securities: [Amend]NASDAQ:CELCCelcuity Inc
22/11/202314h15Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:CELCCelcuity Inc
 Showing the most relevant articles for your search:NASDAQ:CELC

Kürzlich von Ihnen besucht

EU
SPEEU
BNP Paribas Easy S&P 500...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten